Michael Baker

Apr 7, 2026

Section 232 Drug Tariffs Aren’t Health Policy

Executive Summary The Trump Administration announced a new Section 232 tariff regime targeting patented pharmaceuticals and associated pharmaceutical ingredients, tying the policy to...